Search Within

Radiology, Department of

Formats
  1. Journal Article (4815)
  2. Meeting Abstract (1958)
  3. Review (414)
  4. Book Section (413)
  5. Editorial (138)
  6. Conference Paper (98)
  7. Guidelines (75)
  8. Miscellaneous (32)
  9. Research Letter (29)
  10. Correspondence (26)
  11. Book Whole (23)
Groups
  1. Molecular Imaging and Therapy Service (3100)
  2. GSK Faculty (2929)
  3. Body Imaging Service (2590)
  4. Department of Medicine (2409)
  5. Sloan Kettering Institute Postdocs (1930)
  6. Sloan Kettering Institute Faculty (1869)

More Groups

People
  1. Steven Larson (962)
  2. Heiko Schoder (554)
  3. Jason Lewis (463)
  4. Stephen Solomon (430)
  5. Hedvig Hricak (422)
  6. Neeta Pandit-Taskar (348)

More People

Years
  1. 2025 (268)
  2. 2024 (441)
  3. 2023 (497)
  4. 2022 (491)
  5. 2021 (450)
  6. 2020 (470)

More Years

Publications
  1. Journal of Nuclear Medicine (703)
  2. Journal of Clinical Oncology (626)
  3. American Journal of Roentgenology (265)
  4. Radiology (250)
  5. Journal of Vascular and Interventional Radiology (191)
  6. International Journal of Radiation Oncology, Biology, Physics (163)

More Publications

Publishers
  1. Springer (940)
  2. Elsevier Inc. (736)
  3. Society of Nuclear Medicine (703)
  4. American Society of Clinical Oncology (666)
  5. Elsevier Science, Inc. (482)
  6. American Association for Cancer Research (360)

More Publishers

Results (8021)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase II study of PDR001 in combination with MAPK pathway inhibitors in patients with radioactive-refractory differentiated thyroid cancer (DTC)
    Meeting Abstract

    Wong, W.; Sherman, E. J.; Kriplani, A.; Michel, L.; Zhi, I.; Hung, T. K. W.; Dunn, L.; Grewal, R. K.; Krishnamoorthy, G.; Ostrovnaya, I.; more...
    Annals of Oncology (2024)

    Fulltext@MSK | Save
  • An open label phase IIa study evaluating the preliminary efficacy of intratumoural tigilanol tiglate (TT) in advanced and/or metastatic soft tissue sarcoma (STS)
    Meeting Abstract

    Bartlett, E. K.; Li, D.; Shemla, S.; Ariyan, C. E.; Dickinson, S.; Crago, A.; Li, G.; Agaram, N.; D'Angelo, S. P.; Maki, R. G.; more...
    Annals of Oncology (2024)

    Fulltext@MSK | Save
  • A phase II study of palbociclib combined with the PD-1 inhibitor retifanlimab in patients with advanced dedifferentiated liposarcoma
    Meeting Abstract

    Rosenbaum, E.; Qin, L. X.; Dickson, M.; Movva, S.; Kelly, C. M.; Chan, J.; Chi, P.; Banks, L.; Keohan, M. L.; Gounder, M.; more...
    Annals of Oncology (2024)

    Fulltext@MSK | Save
  • Validation of automated bone scan index as a progression endpoint in two phase III studies of metastatic castration resistant prostate cancer (mCRPC) patients
    Meeting Abstract

    Knezevic, A.; Heller, G.; Sjöstrand, K.; Anand, A.; Borzillo, G.; Larson, S.; Morris, M. J.
    Annals of Oncology (2024)

    Fulltext@MSK | Save
  • Prostate cancer working group 4 (PCWG4) preliminary criteria using serial PSMA PET/CT for response evaluation: Analysis from the PRINCE trial
    Meeting Abstract

    Hofman, M. S.; Gafita, A.; Bressel, M.; Alipour, R.; Levy, S.; Emmett, L.; Ravi Kumar, A. S.; Hamid, A. A.; Buteau, J. P.; Kuo, P. H.; more...
    Annals of Oncology (2024)

    Fulltext@MSK | Save
  • Outcomes by baseline tumour burden in EMERALD-1: A phase III, randomised, placebo (PBO)-controlled study of durvalumab (D) ± bevacizumab (B) with transarterial chemoembolisation (TACE) in participants (pts) with embolisation-eligible unresectable hepatocellular carcinoma (uHCC)
    Meeting Abstract

    Kudo, M.; Lencioni, R.; Erinjeri, J. P.; Chan, S. L.; Qin, S.; Ren, Z.; Arai, Y.; Heo, J.; Breder, V.; Bouattour, M.; more...
    Annals of Oncology (2024)

    Fulltext@MSK | Save
  • Phase II multicenter, randomized, double-blind, placebo-controlled study evaluating the efficacy of HB-200 in patients with detectable TTMV-HPV DNA after definitive treatment for HPV16 + HNSCC
    Meeting Abstract

    Ho, A. L.; Riaz, N.; Pfister, D.; Wong, R.; Lee, N.; Sherman, E. J.; Haque, S.; Ostrovnaya, I.; Wong, W.
    Annals of Oncology (2024)

    Fulltext@MSK | Save
  • Persistence and resistance of HER2 amplification after T-DM1 in a basket trial for patients with solid tumors
    Meeting Abstract

    Liu, D.; Arora, K.; Makker, V.; Buonocore, D.; Shen, R.; Yaeger, R.; Ginsberg, M. S.; Yeh, R.; Offin, M. D.; Solit, D.; more...
    Annals of Oncology (2024)

    Fulltext@MSK | Save
  • SOLARIS (Alliance A021703): A multicenter double-blind phase III randomized clinical trial (RCT) of vitamin D (VitD) combined with standard chemotherapy plus bevacizumab (bev) in patients (pts) with previously untreated metastatic colorectal cancer (mCRC)
    Meeting Abstract

    Ng, K.; Ou, F. S.; Zemla, T.; McCleary, N.; Kalyan, A.; Shusterman, M.; Vijayvergia, N.; Wu, C.; Cohen, S. A.; Pulsipher, S.; more...
    Annals of Oncology (2024)

    Fulltext@MSK | Save
  • Pembrolizumab for front-line treatment of extranodal NK/T-cell lymphoma
    Meeting Abstract

    Moskowitz, A.; Advani, R. H.; Ganesan, N.; Chang, T.; Hancock, H.; Davey, T.; Miller, T.; Gibaldi, A.; Smith, M.; Assini, A.; more...
    Blood (2024)

    Fulltext@MSK | Save